Animal Drug Compounding Market is Slated to Reach US$ 3,566.4 Mn by 2030

Animal Drug Compounding Market: Introduction

Reports and Insights predict that the global animal drug compounding market is expected to grow at a CAGR of 7.5% during the forecast period from 2022 to 2030. Furthermore, the total value of the global animal drug compounding market is slated to reach US$ 3,566.4 Mn by 2030, rising from US$ 1,993.1 Mn in 2022.

Stakeholders in the compounding of animal medications have profited greatly as manufacturing and the pharmaceutical sectors have grown substantially in recent years. Growing knowledge of animal health has led to a rise in demand for compounded animal medications.

Because legally licenced pharmaceuticals are not always accessible, compound medications are a better option for treating a variety of ailments. For instance, chewable pills are commercially licenced medications in specific dosage forms and are advised for use in certain animal species but not in animals like cats or exotic pets. Similarly, to this, certain commercially available drugs have an unfavourable taste to some animals. Compounding is favoured in this situation, especially for difficult-to-deliver drugs.

Market Report Outlook:

This report on the global animal drug compounding market aims to discuss market dynamics, including market drivers, potential threats and challenges to the market, global animal drug compounding market opportunities for the major players, global animal drug compounding market trends, market segmentation outlook, regional outlook, global animal drug compounding market size, market forecast, market share, as well as the major players operating in the global animal drug compounding market.

Download Free Sample Report

Animal Drug Compounding Market: Dynamics

Growing Companion Animal Population: One of the main factors propelling market expansion is the rise in the number of companion animals. Given that cats and dogs are two of the most prevalent companion animal species in homes throughout the world, manufacturers are concentrating on stepping up their R&D efforts to support the introduction of new and cutting-edge products.

Increasing Anti-Infective Drug Demand: The market's highest demand is for anti-infective medications, which include anti-bacterial, anti-fungal, anti-viral, and antiphrastic medications. These medications are most frequently used to treat or prevent mild infections in animals, but they can also be used to treat more serious infectious disorders like tuberculosis or pneumonia.

It is projected that a substantial barrier to the expansion of the worldwide market for veterinary medications will be the risk of contaminated compounded veterinary pharmaceuticals. Despite the benefits of compounded treatments for animals, the effectiveness of one or more medications has been affected because of a considerable and well-established risk of drug antagonism. The safety of compounded drug compositions is also not guaranteed by the FDA. The lack of such controlled standards for animal care hinders efforts to improve animal welfare.

Animal Drug Compounding Market: Regional Outlook

The market for animal medication compounding was dominated by North America in 2021. One of the most important factors propelling the expansion of this regional market is the rise in the number of animal medicine compounding pharmacies in the North American region. The presence of a strong healthcare system that caters to both humans and animals, as well as the early adoption of cutting-edge therapeutic techniques and strategies by veterinarians and other animal healthcare professionals in the region, are some other significant factors driving the growth of the North American market.

On the contrary, it is predicted that in the next years, the Asia Pacific region would have the highest growth in the global market. This development can be ascribed to a rise in pet ownership rates and consumer acceptance of various forms of compounded veterinarian planning and preparation. Over the forecast period, it is also expected that both the Asia Pacific and North American regional markets will grow as a result of increased consumer demand for and availability of compounded medicine formulations that are specifically tailored to their needs.

Animal Drug Compounding Market: Key Players

The foremost entrants in the global animal drug compounding market are; Aurora Compounding, Chiron Compounding Pharmacy, Dougherty's Pharmacy, Hoye's Pharmacy, Medisca Inc., MEDS Canadian Compounding Pharmacy, Millers Pharmacy, Pace Pharmacy, People’s Choice Pharmacy, Pratt’s Compounding Pharmacy, Sixth Avenue Medical Pharmacy, Smith Caldwell Drug Store, Triangle Compounding Pharmacy Inc., Vertisis Custom Pharmacy, Victoria Compounding Pharmacy, and Wedgewood Pharmacy amongst other.

Animal Drug Compounding Market: Segmentation Outlook

Data for growth projections and estimates are included in this study for the Product segment (Anti-Invectives, Anti-Inflammatory, CNS Agents, GI Drugs, and Others); for the Route of Administration (Injectable, Ocular, Oral, Rectal, and Topical); for the Animal Type segment {Companion Animals (Birds, Cats, Dogs, Horses, and Others), and Livestock Animals}; for the Dosage Form segment (Capsules, Powders, Solutions, Suspensions, and Others). The animal drug compounding market forecast period is 2022 to 2030.


Contact Us

Reports and Insights

Tel: +1-(718)-312-8686

For Sales Query[email protected]

For New Topics & Other Info: [email protected]



This site uses cookies, including third-party cookies, that help us to provide and improve our services. Privacy Policy